Biogen (BIIB) EBITDA Margin (2009 - 2026)
Biogen (BIIB) recorded EBITDA Margin of -14.93% in Q2 2026, down 27.53 percentage points from 12.60% a year earlier and down 11.74 percentage points from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) EBITDA Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Biogen's EBITDA Margin came in at -7.51% as of Jun 30, 2026, down 8.37 percentage points year-over-year; for FY2025, it came in at -0.69%, down 3.46 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of -37.93 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at 2.78% in FY2024 (+10.32 pp), -7.54% in FY2023 (-25.55 pp), 18.01% in FY2022 (-12.30 pp) and 30.31% in FY2021 (-6.94 pp).
- Quarterly EBITDA Margin has ranged from -26.71% in Q3 2023 to 40.75% in Q3 2022 over the past five years.
- On a year-over-year basis, EBITDA Margin rose in four of the last eight quarters, with an average year-over-year change of -1.42 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 34.15 percentage points in Q4 2021, against a drop of 67.46 percentage points in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -3.18% (Q1 2026), -15.41% (Q4 2025) and 3.36% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 39.16% |
| 10 | Biogen | 37.51 Bn | 24.16 Bn | 1.96 Bn | -14.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14.93% |
| Mar 31, 2026 | -3.18% |
| Dec 31, 2025 | -15.41% |
| Sep 30, 2025 | 3.36% |
| Jun 30, 2025 | 12.60% |
| Mar 31, 2025 | -5.55% |
| Dec 31, 2024 | -4.40% |
| Sep 30, 2024 | -0.20% |
| Jun 30, 2024 | 12.64% |
| Mar 31, 2024 | 3.06% |
| Dec 31, 2023 | -7.82% |
| Sep 30, 2023 | -26.71% |
| Jun 30, 2023 | 9.48% |
| Mar 31, 2023 | -4.56% |
| Dec 31, 2022 | 6.00% |
| Sep 30, 2022 | 40.75% |
| Jun 30, 2022 | 35.55% |
| Mar 31, 2022 | 29.77% |
| Dec 31, 2021 | 26.40% |
| Sep 30, 2021 | 33.37% |
API Access
Biogen EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();